ArticleFrontiers in immunology2026

Discovery of plasma metabolomic biomarkers and a predictive model for immune checkpoint inhibitor-associated myocarditis: a pilot case-control study.

Zhuoling Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.